Age-related macular degeneration and the aging eye

Clinical Interventions in Aging

Volumn 3, Issue 3, 2008, Pages 473-482

  Ehrlich, Rita ^a   Harris, Alon ^a   Kheradiya, Nisha S ^a   Winston, Diana M ^a   Ciulla, Thomas A ^c   Wirostko, Barbara ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^c METHODIST HOSPITAL   (United States)

Author keywords

Age related macular degeneration; Aging; Blood flow; Eye; Macula; Retina; Vision

Indexed keywords

APOLIPOPROTEIN E; BASIC FIBROBLAST GROWTH FACTOR; CHOLESTEROL; COMPLEMENT FACTOR H; GELATINASE A; GELATINASE B; LIPID; PIGMENT EPITHELIUM DERIVED FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D;

AGED; AGING; ATHEROSCLEROSIS; BRUCH MEMBRANE; CARDIOVASCULAR DISEASE; CHOROID CAPILLARY LAYER; DISEASE ASSOCIATION; DISEASE COURSE; DRUSEN; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; EYE BLOOD FLOW; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; HOMOZYGOSITY; HUMAN; HYPERTENSION; INCIDENCE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHOTORECEPTOR; PIGMENT EPITHELIUM; PREVALENCE; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; RETINA PIGMENT DEGENERATION; REVIEW;

AGED; AGING; BLOOD FLOW VELOCITY; DISEASE PROGRESSION; HUMANS; MACULA LUTEA; MACULAR DEGENERATION;

EID: 54949139970     PISSN: 11769092     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Andreoli CM, Miller JW. 2007. Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol, 18:502-8.
2. Age-Related Eye Disease Study Research Group. 2001. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol, 119:1417-36.
3. Bhutto IA, McLeod DS, Hasegawa T, et al. 2006. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res, 82:99-110.
4. Bird JC, Marshall J. 1986. Retinal pigment epithelial detachments in the elderly. Trans Soc Ophthalmol UK, 105:674-82.
5. Boehm AG, Koeller AU, Pillunat LE. 2005. The effect of age on optic nerve head blood flow. Invest Ophthalmol Vis Sci, 46:1291-5.
6. Bressler NM, Bressler SB, Fine SL 1988. Age-related macular degeneration. Surv Ophthalmol, 32:375-413.
7. Bressler S, Maguire G, Bressler N, et al. 1990. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. Arch Ophthalmol, 108:1442-7.
8. Burns RP, Feeney-Burns L. 1980. Clinico-morphologic correlations of drusen of Bruch's membrane. Trans Am Ophthalmol Soc, 78:206-25.
9. Cai J, Wu M, Nelson KC, et al. 1999. Oxidant-induced apoptosis in cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci, 40:959-66.
10. Chen SJ, Cheng CY, Lee AF, et al. 2001. Pulsatile ocular blood flow in asymmetric exudative age related macular degeneration. Br J Ophthalmol, 85:411-15.
11. Ciulla TA, Harris A, Chung HS, et al. 1999. Color Doppler imaging discloses reduced ocular blood flow velocities in nonexudative age-related macular degeneration. Am J Ophthalmol, 128:75-80.
12. Ciulla TA, Harris A, Martin BJ. 2001. Ocular perfusion and age related macular degeneration. Acta Ophthalmol Scand, 79:108-15.
13. Ciulla TA, Harris A, Kagemann L, et al. 2002. Choroidal perfusion perturbations in non-neovascular age related macular degeneration. Br J Ophthalmol, 86:209-13.
14. Crabb JW, Miyagi M, Gu X, et al. 2002. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA, 99:14682-7.
15. Curcio CA, Millican CL, Bailey T, et al. 2001. Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci, 42:265-74.
16. de Jong PT. 2006. Age related macular degeneration. N Engl J Med, 355:1474-85.
17. Del Priore LV, Kaplan HJ, Hornbeck R, et al. 1996. Retinal pigment epithelial debridement as a model for the pathogenesis and treatment of macular degeneration. Am J Ophthalmol, 122:629-43.
18. Dimitrova G, Tamaki Y, Kato S. 2002. Retrobulbar circulation in patients with age-related maculopathy. Eye, 16:580-6.
19. Embleton SJ, Hosking SL, Roff Hilton EJ, et al. 2002. Effect of senescence on ocular blood flow in the retina, neuroretinal rim and lamina cribrosa, using scanning laser Doppler flowmetry. Eye, 16:156-62.
20. Feeney-Burns L, Ellersieck MR. 1985. Age-related changes in the ultrastructure of Bruch's membrane. Am J Ophthalmol, 100:686-97.
21. Feeney-Burns L, Hilderbrand ES, Eldridge S. 1984. Aging human RPE: morphometric analysis of macular, equatorial and peripheral cells. Invest Ophthalmol Vis Sci, 25:195-200.
22. Fine SL, Berger JW, Maguire MG, et al. 2000. Age-related macular degeneration. N Engl J Med, 342:483-92.
23. Fitzgerald MEC, Tolley E, Jackson B, et al. 2005. Anatomical and functional evidence for progressive age-related decline in parasympathetic control of choroidal blood flow in pigeons. Experimental Eye Research, 81:478-91.
24. Friedman E, Ivry M, Ebert E, et al. 1989. Increased scleral rigidity and age-related macular degeneration. Ophthalmology, 96:104-8.
25. Friedman E, Krupsky S, Lane AM, et al. 1995. Ocular blood flow velocity in age-related macular degeneration. Ophthalmology, 102:640-6.
26. Friedman E. 1997. A hemodynamic model of the pathogenesis of age related macular degeneration. Am J Ophthalmol, 124:677-82.
27. Friedman E. 2000. The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am J Ophthalmol, 130:658-63.
28. Friedman E. 2004. Update of the vascular model of AMD. Br J Ophthalmol, 88:161-3.
29. Gold B, Merriam JE, Zernant J, et al. 2006. Variation in factor B (FB) and complement 2 (C2) genes is associated with age related macular degeneration. Nat Genet, 38:458-62.
30. Gotoh N, Yamada R, Hiratani H, et al. 2006. No association between complement H gene polymorphism and exudative age related macular degeneration in Japanese. Hum Genet, 120:1-5.
31. Gizzard SW, Arnett D, Haag SL. 2003. Twin study of age related macular degeneration. Ophthalmic Epidemiol, 10:315-22.
32. Groh MJ, Michelson G, Langhans MJ, et al. 1996. Influence of age on retinal and optic nerve head blood circulation. Ophthalmology, 103:529-34.
33. Grunwald JE, Hariparasad SM, DuPont J, et al. 1998. Effect of aging on foveolar choroidal circulation. Arch Ophthalmol, 116:150-4.
34. Grunwald JE, Metelitsina TI, Dupont JC, et al. 2005. Reduced foveolar blood flow in eyes with increased AMD severity. Invest Ophthalmol Vis Sci, 46:1033-8.
35. Harris A, Harris M, Biller J, et al. 2000. Aging affects the retrobulbar circulation differently in women and men. Arch Ophthalmol, 118:1076-80.
36. Henkind P, Gartner S. 1983. The relationship between retinal pigment epithelium and the choriocapillaris. Trans Ophthalmol Soc UK, 103:444-7.
37. Hogg RE, Woodside JV, Gilchrist SE, et al. 2007. Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology, 115:1046-52.
38. Holekamp NM, Bouck N, Volpert O. 2002. Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. Am J Ophthalmol, 134:220-7.
39. Hershko A, Ciechanover A. 1998. The ubiquitin system. Annu Rev Biochem, 67:425-79.
40. Hosal BM, Karakoç G, Gürsel E, et al. 1998. Color Doppler imaging of the retrobulbar circulation in age-related macular degeneration. Eur J Ophthalmol, 8:234-8.
41. Hyman L, Schachat AP, He Q, Leske MC. 2000. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol, 118:351-8.
42. Hyman L, Neborsky R. 2002. Risk factors for age-related macular degeneration: an update. Curr Opin Ophthalmol, 13:171-5.
43. Klaver CC, Wolfs RC, Assink JJ, et al. 1998. Genetic risk of age related maculopathy. Population-based familial aggregation study. Arch Ophthalmol, 116:1646-51.
44. Klein R, Klein BE, Jensen SC, et al. 1997. The five years incidence and progression of age related maculopathy: the Beaver Dam Eye Study. Ophthalmology, 104:7-21.
45. Klein R, Klein BE, Cruickshanks KJ. 1999. The prevalence of age related maculopathy by geographic region and ethnicity. Prog Retin Eye Res, 18:371-89.
46. Klein R, Klein BE, Tomany SC, et al. 2003. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology, 110:273-80.
47. Klein R, Klein BE, Knudtson MD, et al. 2006. Prevalence of age related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology, 113:373-80.
48. Klein R, Klein BE, Knudtson MD, et al. 2007a. Subclinical atherosclerotic cardiovascular disease and early age-related macular degeneration in a multiracial cohort: the Multiethnic Study of Atherosclerosis. Arch Qphthalmol, 125:534-43.
49. Klein R, Deng Y, Klein BE, et al. 2007b. Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study. Am J Ophthalmol, 143:473-83.
50. Lam AKC, Chan ST, Chan H, et al. 2003. The effect of age on ocular blood supply determined by pulsatile ocular blood flow and color Doppler ultrasonography. Optom Vis Sci, 80:305-11.
51. Liang FQ, Godley BF. 2003. Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age related macular degeneration. Experimental Eye Research, 76:397-403.
52. Lutty G, Grunwald J, Majji AB, et al. 1999. Changes in choriocapillaris and retinal pigment epithelium in age-related macular degeneration. Mol Vis, 5:35.
53. Metelitsina TI, Grunwald JE, DuPont JC, et al. 2006. Effect of systemic hypertension on foveolar choroidal blood flow in age related macular degeneration. Br J Ophthalmol, 90:342-6.
54. Mitchell P, Smith W, Attebo K, et al. 1995. Prevalence of age related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology, 102:1450-60.
55. Mori F, Konno S, Hikichi T, et al. 2001. Pulsatile ocular blood flow study: decreases in exudative age related macular degeneration. Br J Ophthalmol, 85:531-3.
56. Moshfeghi DM, Blumenkranz MS. 2007. Role of genetic factors and inflammation in age-related macular degeneration. Retina, 27:269-75.
57. Mullins RF, Russell SR, Anderson DH, et al. 2000. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J, 14:835-46.
58. National Eye Institute. 2007. Statistics and Data. Prevalence of Blindness Data. Data Tables [online]. Accessed Sept 18, 2007. URL: http://www.nei.nih.gov/eyedata/pbd_tables.asp.
59. Nishiyama Y, Mori K, Young-Duvall J, et al. 2001. Aging changes of the choroidal dye filling pattern in indocyanine green angiography of normal subjects. Retina, 21:237-42.
60. Otani A, Takagi H, Oh H, et al. 2002. Vascular endothelial growth factor family and receptor expression in human choroidal neovascular membranes, Microvasc Res, 64:162-9.
61. Pallikaris IG, Kymionis GD, Ginis HS, et al. 2005. Ocular rigidity in living human eyes. Invest Ophthalmol Vis Sci, 46:409-14.
62. Patel N, Adewoyin T, Chong NV. 2007. Age related macular degeneration: a perspective on genetic studies. Eye, 11 May: doi:10.1038/ sj.eye.6702844.
63. Pauleikoff D, Spital G, Radermacher M, et al. 1999. A fluorescein and indocyanine green angiographic study of choriocapillaries in age related macular degeneration. Arch Ophthalmol, 117:1353-8.
64. Ramrattan RS, van der Schaft TL, Moony CM, et al. 1994. Morphometric analysis of Bruch's membrane, the choriocapillaris and chorid in aging. Invest Ophthalmol Vis Sci, 35:2857-64.
65. Ravalico G, Toffoli G, Pastori G, et al. 1996. Age related ocular blood flow changes. Invest Ophthalmol Vis Sci, 37:2645-50.
66. Rizzo JF, Feke GT, Goger DG, et al. 1991. Optic nerve head blood speed as a function of age in normal human subject. Invest Ophthalmol Vis Sci, 32:3263-72.
67. Ross R, Barofsky J, Cohen G, et al. 1998. Presumed macular choroidal watershed vascular filling, choroidal neovascularization, and systemic vascular disease in patients with age related macular degeneration. Am J Ophthalmol, 125:71-80.
68. Salter JM, Cassone VM, Wilkerson MK, et al. 1998. Ocular and regional cerebral blood flow in aging Fischer-344 rats. J Appl Physiol, 85:1024-9.
69. Salvi SM, Akhtar S, Currie Z. 2006. Ageing changes in the eye. Postgrad Med J, 82:581-7.
70. Sandhu R, Sivaprasad S, Shah SP, et al. 2007. Pulsatile ocular blood flow in asymmetric age-related macular degeneration. Eye, 21:506-11.
71. Sato E, Feke GT, Menke MN, et al. 2006. Retinal haemodynamics in patients with age-related macular degeneration. Eye, 20:697-702.
72. Sarks S, Cherepanoff S, Killingsworth M, et al. 2007. Relationship of basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degeneration. Invest Ophthalmol Vis Sci, 48:968-77.
73. Seddon JM, Ajani UA, Mitchell BD. 1997. Familial aggregation of age related maculopathy. Am J Ophthalmol, 123:199-206.
74. Seddon JM, Francis PJ, George S, et al. 2007. Association of CHF Y402H and LOC387715 A69S with progression of age related macular degeneration. JAMA, 297:1793-800.
75. Shang F, Taylor A. 2004. Function of the ubiquitin proteolytic pathway in the eye. Exp Eye Res, 78:1-14.
76. Sivaprasad S, Bailey TA, Chong VN. 2005. Bruch's membrane and the vascular intima: is there a common basis for age-related changes and disease? Clin Experiment Ophthalmol, 33:518-23.
77. Spraul CW, Lang GE, Grossniklaus HE. 1996. Morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci, 37:2724-35.
78. Spraul CW, Grossniklaus HE. 1997. Characteristics of Drusen and Bruch's membrane in postmortem eyes with age-related macular degeneration. Arch Ophthalmol, 115:267-73.
79. Steen B, Sejersen S, Berglin L, et al. 1998. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes. Invest Ophthalmol Vis Sc, 39:2194-200.
80. Suzuki M, Kamei M, Itabe H, et al. 2007. Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration. Mol Vis, 13:772-8.
81. Swaroop A, Branham KE, Chen W, et al. 2007. Genetic susceptibility to age related macular degeneration: a paradigm for dissecting complex disease traits. Hum Mol Genet, 16:R174-82.
82. Thakkinstian A, Han P, McEvoy M, et al. 2006. Systematic review and meta analysis of the association between complement factor H Y402H polymorphism and age related macular degeneration. Hum Mol Genet, 15:2784-90.
83. Topouzis F, Coleman AL, Harris A, et al. 2006. Prevalence of age-related macular degeneration in Greece: the Thessaloniki Eye Study. Am J Ophthalmol, 142:1076-9.
84. Uretmen O, Akkin C, Erakgün T, et al. 2003. Color Doppler imaging of choroidal circulation in patients with asymmetric age-related macular degeneration. Ophthalmologica, 217:137-42.
85. Vingerling JR, Dielemans I, Bots ML, et al. 1995a. Age-related macular degeneration is associated with atherosclerosis: The Rotterdam Study. Am J Epidemiol, 142:404-9.
86. Vingerling JR, Dielemans I, Hofman A, et al. 1995b. The prevalence of age related maculopathy in the Rotterdam Study. Ophthalmology, 102:205-10.
87. Yannuzzi LA, Negrão S, Iida T, et al. 2001. Retinal angiomatous proliferation in age-related macular degeneration. Retina, 21:416-34.
88. Yates JR, Sepp T, Matharu BK, et al. 2007. Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med, 357:553-61.
89. Zarbin MA. 2004. Current concepts in the pathogenesis of age related macular degeneration. Arch Ophthalmol, 122:598-614.